Reports for ATHENA PHARMACEUTIQUES SAS

Company Name

ATHENA PHARMACEUTIQUES SAS

Totals

Shortage reports

4

Actual shortage: 0 (0%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 4 (100%)

Discontinuation Reports

0

To be discontinued: 0
Discontinued: 0
Reversed: 0

Late reports

2 (50%)

Overdue reports

0 (0%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ATHENA-ONDANSETRON ODT 8MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-12-05 2022-05-19 68662
ATHENA-ONDANSETRON ODT 4MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-12-05 2022-05-19 68659
ATHENA-ONDANSETRON ODT 8MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-11-13 2017-11-27 29122
ATHENA-ONDANSETRON ODT 4MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-15 2017-09-07 10326

Showing 1 to 4 of 4

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports

Showing 1 to 0 of 0